Inventor · disambiguated record
Alessia Petrocchi
Also filed as: PETROCCHI ALESSIA
22 granted patents·14 pending applications·342 citations·filing 2002–2022
95Inventor score
Files withANGELETTI P IST RICHERCHE BIO9UNIV TEXAS8BOARD OF REGENTS UNIV OF TEXAS SYSTEM3MERCK SHARP & DOHME3ALTMAN MICHAEL D2
Top patents by PatentIndex Score
36 records- 0197US7217713B2N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2006·Granted May 15, 2007·55 cites·12 claims
- 0297US7169780B2N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2002·Granted Jan 30, 2007·95 cites·44 claims
- 0395US7435734B2N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2006·Granted Oct 14, 2008·36 cites·14 claims
- 0494US7459452B2Dihydroxypyrimidine carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2006·Granted Dec 2, 2008·22 cites·18 claims
- 0594US7232819B2Dihydroxypyrimidine carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2002·Granted Jun 19, 2007·56 cites·46 claims
- 0693US11713313B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Aug 1, 2023·3 cites·12 claims
- 0792US10738043B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2018·Granted Aug 11, 2020·6 cites·12 claims
- 0891US10125128B2GLS1 inhibitors for treating diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Nov 13, 2018·13 cites·21 claims
- 0989US9115120B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2013·Granted Aug 25, 2015·9 cites·9 claims
- 1087US9290490B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Mar 22, 2016·12 cites·25 claims
- 1184US7119073B2Peptides and their use as inhibitors of hepatitis C virus ns3 proteaseANGELETTI P IST RICHERCHE BIO·Filed 2002·Granted Oct 10, 2006·14 cites·20 claims
- 1283US9481692B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted Nov 1, 2016·4 cites·10 claims
- 1382US10208059B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Feb 19, 2019·3 cites·6 claims
- 1481US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 1580US11001594B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2018·Granted May 11, 2021·1 cites·12 claims
- 1680US9018380B2Heterocyclic modulators of HIF activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Granted Apr 28, 2015·7 cites·10 claims
- 1777US7820660B2N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2008·Granted Oct 26, 2010·1 cites·3 claims
- 1871US9487504B2Imidazolyl analogs as syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·1 cites·7 claims
- 1958US2011034449A1N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integraseANGELETTI P IST RICHERCHE BIO·Filed 2010·Application pending·0 cites
- 2056US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 2155US2010099695A1HCV NS3 Protease InhibitorsLIVERTON NIGEL J·Filed 2007·Application pending·0 cites
- 2250US8354545B23,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2008·Granted Jan 15, 2013·0 cites·14 claims
- 2350US2011257162A1Hiv integrase inhibitorsSUMMA VINCENZO·Filed 2011·Application pending·0 cites
- 2448US11046649B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 2546US9670196B2Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 6, 2017·0 cites·15 claims
- 2646US2024109900A1Azabicyclic shp2 inhibitorsIRBM S P A·Filed 2022·Application pending·0 cites
- 2745US2014073634A1Heterocyclic modulators of hif activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Application pending·0 cites
- 2843US2024239799A1(s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo [1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancerC N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING·Filed 2022·Application pending·0 cites
- 2943US2022289753A1Shp2 inhibitorsIRBM S P A·Filed 2020·Application pending·0 cites
- 3042US11173145B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2018·Granted Nov 16, 2021·0 cites·27 claims
- 3141US2008221157A1Amide Derivatives as Inhibitors of Histone DeacetylaseANGELETTI P IST RICHERCHE BIO·Filed 2005·Application pending·0 cites
- 3241US2019135793A1Heterocyclic inhibitors of kdm5 for the treatment of diseaseUNIV TEXAS·Filed 2018·Application pending·0 cites
- 3341US2009136449A1Tetracyclic Indole Derivatives as Antiviral AgentsDI FILIPPO MARCELLO·Filed 2006·Application pending·0 cites
- 3440US2016060260A1Bromodomain inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3537US2005130997A1Pyrimidinone viral polymerase inhibitorsFiled 2003·Application pending·0 cites
- 3634US2008262035A1Amide Derivatives as Inhibitors of Histone DeacetylaseCHAKRAVARTY PRASUN K·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →